BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28116594)

  • 1. Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics.
    Hsu CS; Wen SH; Hung JS; Liu TT; Yi CH; Lei WY; Pace F; Chen CL
    Dig Dis Sci; 2017 Apr; 62(4):994-1001. PubMed ID: 28116594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease.
    Lei WY; Chang WC; Wen SH; Wong MW; Hung JS; Yi CH; Liu TT; Hsu CS; Orr WC; Vaezi MF; Pace F; Hsieh TC; Chen CL
    J Formos Med Assoc; 2019 Apr; 118(4):797-806. PubMed ID: 30584006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, metabolic, and psychological characteristics in patients with gastroesophageal reflux disease overlap with irritable bowel syndrome.
    Hsu CS; Liu TT; Wen SH; Wang CC; Yi CH; Chen JH; Lei WY; Orr WC; Fabio P; Chen CL
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):516-22. PubMed ID: 25822860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study.
    Lee SY; Lee KJ; Kim SJ; Cho SW
    Digestion; 2009; 79(3):196-201. PubMed ID: 19342860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population.
    Rasmussen S; Jensen TH; Henriksen SL; Haastrup PF; Larsen PV; Søndergaard J; Jarbøl DE
    Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome.
    Fujiwara Y; Kubo M; Kohata Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    Intern Med; 2011; 50(21):2443-7. PubMed ID: 22041340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.
    Futagami S; Yamawaki H; Shimpuku M; Izumi N; Wakabayashi T; Kodaka Y; Nagoya H; Shindo T; Kawagoe T; Sakamoto C
    J Nippon Med Sch; 2013; 80(5):362-70. PubMed ID: 24189354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroesophageal reflux disease in a typical African population: a symptom-based multicenter study.
    Nwokediuko SC; Adekanle O; Akere A; Olokoba A; Anyanechi C; Umar SM; Maiyaki A; Ijoma U; Obienu O; Uhunmwangho A; Ndububa D
    BMC Gastroenterol; 2020 Apr; 20(1):107. PubMed ID: 32293291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and psychosocial impact of different reflux time in gastroesophageal reflux disease patients.
    Chen JH; Wen SH; Hsu CS; Yi CH; Liu TT; Chen CL; Wang CC
    J Formos Med Assoc; 2017 Feb; 116(2):123-128. PubMed ID: 27133182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
    Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and psychological characteristics in gastroesophageal reflux disease patients overlapping with laryngopharyngeal reflux symptoms.
    Wong MW; Bair MJ; Chang WC; Hsu CS; Hung JS; Liu TT; Yi CH; Lei WY; Vaezi MF; Gyawali CP; Chen CL
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1720-1726. PubMed ID: 30851003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.
    Matsuhashi N; Kudo M; Yoshida N; Murakami K; Kato M; Sanuki T; Oshio A; Joh T; Higuchi K; Haruma K; Nakada K
    J Gastroenterol; 2015 Dec; 50(12):1173-83. PubMed ID: 25851931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of a modified Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease to distinguish functional dyspepsia from non-erosive reflux disease.
    Kusano M; Hosaka H; Kawada A; Kuribayashi S; Shimoyama Y; Kawamura O; Moki F
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1187-91. PubMed ID: 22414314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Belching: dyspepsia or gastroesophageal reflux disease?
    Lin M; Triadafilopoulos G
    Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations among gastroesophageal reflux disease, psychological stress, and sleep disturbances in Japanese adults.
    Okuyama M; Takaishi O; Nakahara K; Iwakura N; Hasegawa T; Oyama M; Inoue A; Ishizu H; Satoh H; Fujiwara Y
    Scand J Gastroenterol; 2017 Jan; 52(1):44-49. PubMed ID: 27571846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
    Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
    Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study.
    Lembo A; Zaman M; Jones M; Talley NJ
    Aliment Pharmacol Ther; 2007 Jun; 25(11):1343-50. PubMed ID: 17509102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for functional dyspepsia, erosive and non-erosive gastroesophageal reflux disease: A cross-sectional study.
    Caballero-Mateos AM; López-Hidalgo JL; Torres-Parejo Ú; Hernández-González JM; Quintero-Fuentes MD; Caballero-Plasencia AM; Redondo-Cerezo E
    Gastroenterol Hepatol; 2023; 46(7):542-552. PubMed ID: 36584749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of upper gastrointestinal symptoms in Brazil (EpiGastro): a population-based study according to sex and age group.
    do Rosário Dias de Oliveira Latorre M; Medeiros da Silva A; Chinzon D; Eisig JN; Dias-Bastos TR
    World J Gastroenterol; 2014 Dec; 20(46):17388-98. PubMed ID: 25516650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of symptoms in gastroesophageal reflux disease: nonerosive reflux disease, symptomatic, and silent erosive reflux disease.
    Choi JY; Jung HK; Song EM; Shim KN; Jung SA
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):764-71. PubMed ID: 23459104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.